Search This Blog

Tuesday, September 29, 2020

Orphazyme A/S raised $84M in IPO

Danish biopharma Orphazyme A/S (ORPH) has priced 7.6M ADS at $11, below the previous expected price of $13.13/ADS.

At pricing, the company raised -16% less in proceeds than anticipated.

Source

https://seekingalpha.com/news/3618022-orphazyme-s-raised-84m-in-ipo

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.